The Institutions, Mutual Funds, Pensions, Insurance Companies, ETFs whose job it is to primarily preserve capital while earning a reasonable ROI and possible dividends will not invest until the current group of shareholders carry the risk across the goal lines of approval and profitability. They will gladly pay $30 per share to those that bought at $3 for carrying that risk then resolved. There will be more risk tolerant aggressive fund investors who will pay the $7-10 to those that bought at $0.50 - 1.20 once another few risks are removed. Namely uplifting to AMEX NASDAQ or NYSE and acceptance of the BLA and the PDUFA Date which could happen as soon as this week and result in a major leg up. It will definately be a major milestone and a watershed event in the history of CytoDyn I would not be surprised to see a major months long run up in the share price as the strength of the trial data and safety profile of Leronlimab is so impressive as FDA Approval will seem almost assured.
CYDY has the potential to be the trade of the decade for those willing to hold a few months and stake a reasonable amount. CYDY has the potential to create generational wealth for those willing to stake an unreasonablely large amount and hold for a decade.
Ask yourselves why there is so much negative Psych Ops on this board if CYDY was not a potentially disruptive Biotech and potentially a near term multi bagger investment. There can't be that many short seller's currently underwater as it would be suicide to be short CYDY at this point in time. Therefore this negativity is mostly coming from unscrupulous longs and traders trying to stake a larger claim, jealous outsiders and Competing Interests to CytoDyn wishing it harm. Certainly no rational person would honestly harbor some of the unreasonable and unfounded fears expressed about CYDY.
Market Data 
Markets 
AI
